Stay updated on Pediatric Tolerability of Xerecept in Clinical Trial
Sign up to get notified when there's something new on the Pediatric Tolerability of Xerecept in Clinical Trial page.

Latest updates to the Pediatric Tolerability of Xerecept in Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
- Check9 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check45 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a clinical study involving Xerecept® and its effects on pediatric patients, while also adding a new version revision number.SummaryDifference27%
- Check52 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check96 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
Stay in the know with updates to Pediatric Tolerability of Xerecept in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Tolerability of Xerecept in Clinical Trial page.